These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31798365)

  • 1. Modelling long-term cost-effectiveness of health promotion for community-dwelling older people.
    Zingmark M; Norström F; Lindholm L; Dahlin-Ivanoff S; Gustafsson S
    Eur J Ageing; 2019 Dec; 16(4):395-404. PubMed ID: 31798365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of an intervention focused on reducing bathing disability.
    Zingmark M; Nilsson I; Norström F; Sahlén KG; Lindholm L
    Eur J Ageing; 2017 Sep; 14(3):233-241. PubMed ID: 28936134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome for ADL following the health-promoting RCT--elderly persons in the risk zone.
    Gustafsson S; Eklund K; Wilhelmson K; Edberg AK; Johansson B; Kronlöf GH; Gosman-Hedström G; Dahlin-Ivanoff S
    Gerontologist; 2013 Aug; 53(4):654-63. PubMed ID: 22936539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing disability in community-dwelling frail older people: cost-effectiveness study alongside a cluster randomised controlled trial.
    Metzelthin SF; van Rossum E; Hendriks MR; De Witte LP; Hobma SO; Sipers W; Kempen GI
    Age Ageing; 2015 May; 44(3):390-6. PubMed ID: 25566783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home safety assessment and modification to reduce injurious falls in community-dwelling older adults: cost-utility and equity analysis.
    Pega F; Kvizhinadze G; Blakely T; Atkinson J; Wilson N
    Inj Prev; 2016 Dec; 22(6):420-426. PubMed ID: 27222247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term health outcomes and cost-effectiveness of a computer-tailored physical activity intervention among people aged over fifty: modelling the results of a randomized controlled trial.
    Peels DA; Hoogenveen RR; Feenstra TL; Golsteijn RH; Bolman C; Mudde AN; Wendel-Vos GC; de Vries H; Lechner L
    BMC Public Health; 2014 Oct; 14():1099. PubMed ID: 25342517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a pro-active approach of urinary incontinence in women.
    Vermeulen KM; Visser E; Messelink EJ; Schram AJ; Berger MY; de Bock GH; Dekker JH
    BJOG; 2016 Jun; 123(7):1213-20. PubMed ID: 26834046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of health promotion for older people-methodological problems and challenges.
    Huter K; Kocot E; Kissimova-Skarbek K; Dubas-Jakóbczyk K; Rothgang H
    BMC Health Serv Res; 2016 Sep; 16 Suppl 5(Suppl 5):328. PubMed ID: 27609155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
    van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
    Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
    Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the underlying causes of undernutrition. Cost-effectiveness of a multifactorial personalized intervention in community-dwelling older adults: A randomized controlled trial.
    van der Pols-Vijlbrief R; Wijnhoven HAH; Bosmans JE; Twisk JWR; Visser M
    Clin Nutr; 2017 Dec; 36(6):1498-1508. PubMed ID: 27836308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
    Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of the Chlamydia Monday--a community-based intervention to decrease the prevalence of chlamydia in Sweden.
    Deogan CL; Bocangel MK; Wamala SP; Månsdotter AM
    Scand J Public Health; 2010 Mar; 38(2):141-50. PubMed ID: 20064921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can hip protector use cost-effectively prevent fractures in community-dwelling geriatric populations?
    Honkanen LA; Mushlin AI; Lachs M; Schackman BR
    J Am Geriatr Soc; 2006 Nov; 54(11):1658-65. PubMed ID: 17087691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of a preventive home visit program for older adults in Germany.
    Brettschneider C; Luck T; Fleischer S; Roling G; Beutner K; Luppa M; Behrens J; Riedel-Heller SG; König HH
    BMC Health Serv Res; 2015 Apr; 15():141. PubMed ID: 25884452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modelling-based economic evaluation of primary-care-based fall-risk screening followed by fall-prevention intervention: a cohort-based Markov model stratified by older age groups.
    Franklin M; Hunter RM
    Age Ageing; 2019 Dec; 49(1):57-66. PubMed ID: 31711110
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.